Enter your email address below and subscribe to our newsletter

Surgery

Share your love

Melt Pharma Raises $24M for Sedation Tablet

Melt Pharmaceuticals has successfully completed a significant financial milestone, securing approximately $24 million through its Series B Preferred Stock financing round. This latest funding round saw contributions from both new and returning investors, setting the stage for the accelerated development…

Pantheon Vision Gets Another $1.8M for Corneal Implants

Pantheon Vision, a pioneering medical device company in the pre-clinical stage focused on developing bioengineered corneal implants, has secured an additional $1.8 million in funding. This recent financial boost is part of a second tranche from KeraLink International (KLI), following…

ViaLase Raises $40M for Glaucoma Laser Tech

ViaLase has successfully completed a Series C financing round, raising a substantial $40 million. This funding boost is set to accelerate the development, regulatory approval, and commercialization efforts of the ViaLase Laser, a pioneering medical device developed for the treatment…

Alcon Names Terry Kim, MD as Chief Medical Officer

Alcon announced the appointment of Terry Kim, MD, as the company’s new Chief Medical Officer (CMO) and Head of Global Medical Safety, starting in April. Dr. Kim, a renowned figure in the field of ophthalmology, brings a wealth of experience…

ASCRS Congress 2024 Set to Take Place in April 5-8

From April 5 to 8, 2024, the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting is set to take place in Boston, USA, at the Boston Convention & Exhibition Center. This annual meeting is a pivotal event for…

ABVC BioPharma and ForSeeCon Ink Global Agreement

ABVC BioPharma, Inc. has entered into a significant global licensing agreement with ForSeeCon Eye Corporation (FEYE), marking a pivotal moment for the clinical-stage biopharmaceutical company known for its developments in ophthalmology, CNS, and oncology The agreement focuses on ABVC’s ophthalmology…

Rayner Reduces Carbon with Green Packaging

Rayner announced a significant update to its packaging, marking a pivotal step towards achieving its environmental objectives while also enhancing the customer experience. The company has introduced several innovative changes designed to reduce its carbon footprint and improve the practicality…

Algae-Derived Hydrogel Offers Hope for Retinal Detachment

A recent study has introduced an innovative approach to treating retinal detachment through an artificial vitreous body made from alginate, a natural carbohydrate extracted from algae. This research represents a collaboration among experts from Pohang University of Science and Technology…

2023 Recap: Top 20 Ophthalmic Collaborations of the Year

As we bid farewell to 2023, it’s time to reflect on the remarkable collaborations that have shaped the landscape of ophthalmic innovation. The past year witnessed groundbreaking partnerships between pharmaceutical giants, tech innovators, and research institutions, all aimed at advancing…

Top 12 Gene Therapies for Eye Diseases and Blindness

In a groundbreaking era of medical research, scientists and clinicians are spearheading novel gene therapies that hold promise for transforming the landscape of eye disease treatment. These cutting-edge interventions address a spectrum of conditions ranging from Usher Syndrome and retinoschisis…

Stay informed and not overwhelmed, subscribe now!